In-Silico Drug Discovery Market

In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development ? from the initial lead designing to final stage clinical development.

In-Silico Drug Discovery Market contains market size and forecasts of In-Silico Drug Discovery in Global, including the following market information:

Global In-Silico Drug Discovery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global In-Silico Drug Discovery market was valued at 2048.6 million in 2021 and is projected to reach US$ 4358.6 million by 2028, at a CAGR of 11.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Software as a Service (Cloud) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In-Silico Drug Discovery include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schr?dinger, Inc., GVK BIO and OpenEye Scientific Software and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the In-Silico Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In-Silico Drug Discovery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In-Silico Drug Discovery Market Segment Percentages, by Type, 2021 (%)

• Software as a Service (Cloud)
• Consultancy as a Service
• Software

Global In-Silico Drug Discovery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In-Silico Drug Discovery Market Segment Percentages, by Application, 2021 (%)

• Contract Research Organization
• Pharmaceutical Industry
• Academic and Research Institutes
• Others

Global In-Silico Drug Discovery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In-Silico Drug Discovery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies In-Silico Drug Discovery revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies In-Silico Drug Discovery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Charles River
• Certara USA, Inc.
• Evotec
• Dassault System (Biovia)
• Albany Molecular Research Inc. (AMRI)
• Selvita
• Schr?dinger, Inc.
• GVK BIO
• OpenEye Scientific Software
• Chemical Computing Group (CCG)